OBJECTIVE: To develop and evaluate a competitive ELISA (cELISA) specific for detection of antibodies to abortion strains of Chlamydia psittaci and C pecorum that is based on monoclonal antibodies against the 2 segments. PROCEDURA: Monoclonal antibodies were screened for binding to ELISA plates coated with elementary bodies, and were selected on the basis of positive competition with experimentally produced sera against C psittaci and lack of competition with anti-C pecorum sera. The cELISA was evaluated with field sera, and the results were compared with those obtained by complement-fixation testing and by an ELISA containing solubilized outer membrane complexes (A-ELISA). RESULTS: The cELISA detected 9 of 10 C psittaci-infected flocks (57/125 sera, 45.6%), and in 6 of 10 flocks (27.3% of the sera), it specified correctly the infecting chlamydial species. Regarding test sensitivity, the complement-fixation test detected 6 of 10 test-positive (19.2% of the sera) flocks, whereas 7 of 10 test-positive (48.8% of the sera) flocks were detected by use of the A-ELISA. The specificity of the test was satisfactory (100%), compared with the A-ELISA (72.2%). CONCLUSIONS: The new cELISA is a sensitive and specific assay for antibodies against C psittaci abortion strains. It is rapid and easy to perform and does not require serum dilutions. The new cELISA is, therefore, suitable as a routine test for chlamydial diagnosis and seroepidemiologic studies.
OBJECTIVE: To develop and evaluate a competitive ELISA (cELISA) specific for detection of antibodies to abortion strains of Chlamydia psittaci and C pecorum that is based on monoclonal antibodies against the 2 segments. PROCEDURA: Monoclonal antibodies were screened for binding to ELISA plates coated with elementary bodies, and were selected on the basis of positive competition with experimentally produced sera against C psittaci and lack of competition with anti-C pecorum sera. The cELISA was evaluated with field sera, and the results were compared with those obtained by complement-fixation testing and by an ELISA containing solubilized outer membrane complexes (A-ELISA). RESULTS: The cELISA detected 9 of 10 C psittaci-infected flocks (57/125 sera, 45.6%), and in 6 of 10 flocks (27.3% of the sera), it specified correctly the infecting chlamydial species. Regarding test sensitivity, the complement-fixation test detected 6 of 10 test-positive (19.2% of the sera) flocks, whereas 7 of 10 test-positive (48.8% of the sera) flocks were detected by use of the A-ELISA. The specificity of the test was satisfactory (100%), compared with the A-ELISA (72.2%). CONCLUSIONS: The new cELISA is a sensitive and specific assay for antibodies against C psittaci abortion strains. It is rapid and easy to perform and does not require serum dilutions. The new cELISA is, therefore, suitable as a routine test for chlamydial diagnosis and seroepidemiologic studies.
Authors: Irene Schiller; H Martin Vordermeier; W Ray Waters; Mitchell Palmer; Tyler Thacker; Adam Whelan; Roland Hardegger; Beatrice Marg-Haufe; Alex Raeber; Bruno Oesch Journal: Clin Vaccine Immunol Date: 2009-07-08
Authors: Yvonne Pannekoek; Veerle Dickx; Delphine S A Beeckman; Keith A Jolley; Wendy C Keijzers; Evangelia Vretou; Martin C J Maiden; Daisy Vanrompay; Arie van der Ende Journal: PLoS One Date: 2010-12-02 Impact factor: 3.240